Full View

Temsirolimus maintenance therapy after docetaxel induction in castration-resistant prostate cancer

U Emmenegger, CM Booth, S Berry, SS Sridhar… - The …, 2015 - academic.oup.com
Abstract Lessons Learned. Temsirolimus maintenance therapy after docetaxel induction
chemotherapy is safe in patients with castration-resistant prostate cancer, although …
被引用次数：16 相关文章

Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer.

U Emmenegger, CM Booth, S Berry, SS Sridhar… - …, 2015 - search.ebscohost.com
Background. No standard therapy is available for men with castration-resistant prostate
cancer (CRPC) who have responded to docetaxel and do not yet have disease progression …
[PDF] wiley.com

[PDF][PDF] Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration‐Resistant Prostate Cancer

U Emmenegger, CM Booth, S Berry, SS Sridhar… - The …, 2015 - Wiley Online Library
Lessons Learned. Temsirolimus maintenance therapy after docetaxel induction
chemotherapy is safe in patients with castration‐resistant prostate cancer, although …

Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer

U Emmenegger, CM Booth, S Berry… - The …, 2015 - pubmed.ncbi.nlm.nih.gov
Lessons learned Temsirolimus maintenance therapy after docetaxel induction
chemotherapyis safe in patients with castration-resistant prostate cancer, although …

Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer

U Emmenegger, CM Booth, S Berry, SS Sridhar… - The Oncologist, 2015 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Lessons Learned.</jats: title><
jats: p> Temsirolimus maintenance therapy after docetaxel induction chemotherapy is safe …

Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer.

U Emmenegger, CM Booth, S Berry, SS Sridhar… - The …, 2015 - europepmc.org
Background No standard therapy is available for men with castration-resistant prostate
cancer (CRPC) who have responded to docetaxel and do not yet have disease progression …
[HTML] nih.gov

[HTML][HTML] Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer

U Emmenegger, CM Booth, S Berry, SS Sridhar… - The …, 2015 - ncbi.nlm.nih.gov
Background. No standard therapy is available for men with castration-resistant prostate
cancer (CRPC) who have responded to docetaxel and do not yet have disease progression …